MIA:
- WHO ATC First Level (Anatomical main group) ID: J ANTIINFECTIVES FOR SYSTEMIC USE
- WHO ATC Second Level (Therapeutic subgroup) ID: J04 ANTIMYCOBACTERIALS
- WHO ATC Third Level (Pharmacological subgroup) ID: J04A DRUGS FOR TREATMENT OF TUBERCULOSIS
- WHO ATC Fourth Level (Chemical subgroup) ID: J04AK Other drugs for treatment of tuberculosis
- WHO ATC Fifth Level (Chemical substance) ID: J04AK01 Pyrazinamide
- Chemical Name: Pyrazinamide
- Chemical Smi: NC(=O)c1cnccn1
- WHO ICD Mapped Level : A23 A23 Name: Brucellosis
- WHO ICD Fourth Level ID: Name:
- WHO ICD Third Level ID: A23 A23 Name: Brucellosis
- WHO ICD Second Level ID: A20-A28 A20-A28 Name: Certain zoonotic bacterial diseases
- WHO ICD First Level ID: I I Name: Certain infectious and parasitic diseases
|
|